# A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

> **NCT05865028** · PHASE2 · RECRUITING · sponsor: **Elizabeth J Franzmann** · enrollment: 32 (estimated)

## Conditions studied

- Oropharyngeal Dysplasia
- Oral Cavity Dysplasia
- Oral Carcinoma in Situ

## Interventions

- **DRUG:** APG-157

## Key facts

- **NCT ID:** NCT05865028
- **Lead sponsor:** Elizabeth J Franzmann
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-24
- **Primary completion:** 2027-05-24
- **Final completion:** 2028-05-24
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05865028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05865028, "A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05865028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*